Status:

COMPLETED

Comparing Chemoprevention Drugs for School-based Malaria Control

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

Kamuzu University of Health Sciences

Doris Duke Charitable Foundation

Conditions:

Malaria,Falciparum

Anemia in Children

Eligibility:

All Genders

6+ years

Phase:

PHASE4

Brief Summary

This is an individually randomized, controlled, single blind three arm clinical trial of malaria chemoprevention strategies Arm 1: Intermittent preventive treatment with dihydroartemisinin-piperaquine...

Detailed Description

Students attending a single primary school in Machinga District, Malawi who were enrolled in NCT05244954 were offered enrollment in this follow-on study. The intervention will be conducted every 6-wee...

Eligibility Criteria

Inclusion

  • Students (enrolled in the primary intervention)
  • Previously enrolled in NCT05244954
  • Currently enrolled in the study school
  • Plan to attend the study school for the remainder of the school year
  • Parent/guardian available to provide written informed consent Younger children in participant households (enrolled in the Household Prevalence survey)
  • Slept in the household for most nights in the last month
  • Age 6-59 months
  • Parent/guardian available to provide written informed consent

Exclusion

  • Students (enrolled in the primary intervention)
  • Current evidence of severe malaria or danger signs
  • Known adverse reaction to the study drugs
  • History of cardiac problems or fainting
  • Taking medications known to prolong QT
  • Family history of prolonged QT
  • Taking trimethoprim-sulfamethoxazole aka Bactrim or Cotrimoxazole
  • Epilepsy
  • Psoriasis Household members (enrolled in the Household Prevalence survey)
  • Household with more than one school-age child enrolled in the study
  • Current evidence of severe malaria or danger signs

Key Trial Info

Start Date :

February 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 28 2023

Estimated Enrollment :

646 Patients enrolled

Trial Details

Trial ID

NCT05980156

Start Date

February 13 2023

End Date

July 28 2023

Last Update

August 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kamuzu University of Health Sciences

Blantyre, Malawi